About This Dashboard

Every package tested in New Jersey's regulated cannabis market, visualized and searchable. 72,098 packages across 133 facilities, 8 labs, and 3,499 strains. January 2023 through December 2025.

The data comes from the NJ Cannabis Regulatory Commission via Metrc. The analysis, visualization, and methodology are mine. The testing data is public record. Making it usable is the contribution.

I'm Max Jackson, founder of Cannabis Wise Guys.

Before I started analyzing cannabis markets, I operated in one. I worked on a licensed cannabis farm in Trinity County, California — first as a photographer documenting the operation, then as general manager running day-to-day cultivation across 13,000 square feet of flowering canopy. I lived on-site in a converted ambulance and learned every lesson the hard way: undersized irrigation, failed automation, diesel generators at 3 AM, two hours from the nearest Home Depot.

Today I work as an operational translator between cannabis operations, finance, and policy. I serve on a state trade organization's cultivation committee, consult on cannabis litigation as an expert witness, and publish market analysis that bridges the gap between what operators experience and what investors and regulators assume.

I built this because I kept citing testing data in policy memos and realized nobody could verify what I was saying without doing the same multi-month data processing I had done. That's a problem. If the evidence matters, the evidence should be public.

Markets work better when participants have access to the same data.

Operators should know what the market looks like: how many facilities are actually producing, what the potency distribution is, which product categories are growing, and what the failure rates are by test type. Right now, most operators are guessing.

Regulators and policymakers should be able to see the same data they collect. A 5-point climb in median flower THC over three years, measurable differences in potency reporting between labs, and data entry errors that passed through Metrc's validation — these are patterns worth understanding, and they are more useful as a shared reference than as findings buried in quarterly exports.

Investors should understand what's real: a market that has tripled in testing volume but is fragmenting faster than it is growing, with 10 facilities producing nearly half of all tested product while the median facility produces 5 packages a month.

The data is already public record. I just made it legible.